98%
921
2 minutes
20
Physical inactivity depresses glycemic control, an impairment that can be prevented with exercise. We investigated whether electrical muscle stimulation (EMS) with blood flow restriction (BFR) could similarly prevent the impairments in glycemic control associated with physical inactivity and whether this was effective for attenuating the loss of physical function after inactivity. Thirty-two participants underwent 1 week of step reduction (≤ 3000 steps/day) randomized to either no intervention (Control), twice daily EMS, or twice daily EMS with BFR (EMS + BFR). Oral glucose tolerance and tests of physical function (neuromuscular function, and cardiorespiratory fitness) were assessed before and after step reduction. Blood glucose incremental area under the curve (iAUC) during the oral glucose tolerance test increased after step reduction (Control: ∆71 ± 133 mM⋅min, EMS: ∆56 ± 65 mM⋅min, EMS + BFR: ∆103 ± 78 mM⋅min, p = 0.0002), as was the insulin iAUC (Control: ∆3580 ± 3245μIU⋅min/mL, EMS: ∆2266 ± 5043μIU⋅min/mL, EMS + BFR: ∆1534 ± 1246μIU⋅min/mL, p = 0.001). A relationship between the change in blood glucose and insulin response was observed after Control (r = 0.71, p = 0.002), but not after EMS + BFR (r < 0.01, p = 0.93), despite all groups demonstrating a reduction in whole-body insulin sensitivity (Matsuda index; Control: ∆-1.4 ± 2.5, EMS: ∆-1.3 ± 1.5, EMS + BFR: ∆-1.5 ± 1.5, p < 0.0001). Maximal oxygen uptake was not reduced after 1 week of inactivity; however, maximal isometric force production and exercise thresholds were reduced across groups. In summary, EMS + BFR did not prevent the decrease in insulin sensitivity nor attenuate measurements of physical function with 1 week of physical inactivity. The relevance of the dissociated insulin and glucose response with EMS + BFR remains to be determined.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/sms.70056 | DOI Listing |
Cell Mol Biol (Noisy-le-grand)
September 2025
M-DT1, Roquefort-les Pins, France.
To date, the closed-loop system represents the best commercialized management of type 1 diabetes. However, mealtimes still require carbohydrate estimation and are often associated with postprandial hyperglycemia which may contribute to poor metabolic control and long -term complications. A multicentre, prospective, non-interventional clinical trial was designed to determine the effectiveness of a novel algorithm to predict changes in blood glucose levels two hours after a usual meal.
View Article and Find Full Text PDFCell Mol Biol (Noisy-le-grand)
September 2025
Medical School, Laboratory of Genetics and Molecular Pathology, University Hassan II, Casablanca, Morocco.
In-stent restenosis remains a significant challenge in interventional cardiology despite technological advancements. This retrospective case-control study conducted at the University Hospital Center Ibn Rochd in Casablanca (2020-2023) examined risk factors associated with coronary in-stent restenosis in 68 patients equally distributed between restenosis and no-restenosis groups. Diabetes emerged as a powerful predictor of restenosis (RR=4.
View Article and Find Full Text PDFDiabetes Ther
September 2025
Department of Diabetes and Endocrinology, Guy's and St Thomas' NHS Trust, London, UK.
Introduction: This post hoc analysis of an A Toujeo Observational Study (ATOS) aims to evaluate the real-world effectiveness and safety of insulin glargine 300 U/ml (Gla-300) in high-risk subgroups of insulin-naïve people with type 2 diabetes (PwT2D) from multiple geographical regions (Asia, the Middle East, North Africa, Latin America, and Eastern Europe).
Methods: In these post hoc analyses of ATOS, a real-world, 12-month, prospective study included 4422 insulin-naïve adults (age ≥ 18 years) with type 2 diabetes (T2D) uncontrolled (HbA > 7% and ≤ 11%) on one or more oral antidiabetic drugs (OADs) who initiated Gla-300 treatment as per routine practice. Primary and secondary endpoints were studied according to renal impairment (RI) status (without or with) and age group (≥ 70 years).
Int J Vitam Nutr Res
August 2025
Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Dhaka, 1000 Dhaka, Bangladesh.
Diabetes mellitus (DM) is a chronic metabolic disorder characterized by persistent hyperglycemia and associated with severe complications, including cardiovascular diseases, neuropathy, nephropathy, and retinopathy. Although synthetic antidiabetic drugs are available, the side effects and limited long-term effectiveness of these medications highlight the urgent need for safer, more potent alternative therapies. L.
View Article and Find Full Text PDFInt J Vitam Nutr Res
August 2025
Department of Endocrinology, Affiliated Hospital of Integrated Chinese and Western Medicine, Nanjing University of Chinese Medicine, 210028 Nanjing, Jiangsu, China.
Background: Dietary interventions have exhibited promise in restoring microbial balance in chronic kidney disease. A low-protein calorie-restricted diet can reduce kidney injury in diabetic rodents. However, whether the renoprotective effects of this dietary intervention in murine diabetic kidney disease models are linked to gut microbiota modulation remains to be determined.
View Article and Find Full Text PDF